Schedule 13D ownership disclosure
AKARI THERAPEUTICS PLC
Ordinary Shares, $0.0001 par value · CUSIP: 00972G207
Event date: 2024-11-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ray Prudo, M.D.Reported CIK 0001653262
Shares: 4,926,600,800 · Class: 9.3%
- RPC Pharma Limited
Shares: 800,766,600 · Class: 1.5%
- Praxis Trustees Limited As trustee of The Sonic Healthcare Holding Company
Shares: 38,709,600 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021393
- Form type
- SCHEDULE 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Feb 14, 2025
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13D beneficial ownership